Seung-Hun Chon

Dr. Seung-Hun Chon

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2018 in European Radiology
Verified
Journal Article
Closed access
PDF file
Daniel Pinto dos SantosDaniel Pinto dos Santos
Daniel Pinto dos Santos
DGD. Giese
D. Giese
Sebastian BrodehlSebastian Brodehl
Sebastian Brodehl
SCSeung-Hun Chon
Seung-Hun Chon
WSW. Staab
W. Staab
BBB. Baeßler
B. Baeßler

22 June 2019 in Cancers
Verified
Journal Article
Open access
PDF file
JZJiangang Zhao
Jiangang Zhao
HSHans Schloesser
Hans Schloesser
ZWZhefang Wang
Zhefang Wang
JQJie Qin
Jie Qin
JLJiahui Li
Jiahui Li
YZYue Zhao
Yue Zhao
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies. Tumor-derived extracellular vesicles (EVs) induce pre-metastatic niche formation to promote metastasis. We isolated EVs from a highly-metastatic pancreatic cancer cell line and patient-derived primary cancer cells by ultracentrifugation. The protein content of EVs was analyzed by mass spectrometry. The effects of PDAC-derived EVs on natural kill (NK) cells were investigated by flow cytometry. The serum EVs’ TGF-β1 levels were quantified by ELISA. We found that integrins were enriched in PDAC-derived EVs. The expression of NKG2D, CD107a, TNF-α, and INF-γ in NK cells was significantly downregulated after co-culture with EVs. NK cells also exhibited decreased levels of CD71 and CD98, as well as impaired glucose uptake ability. In addition, NK cell cytotoxicity against pancreatic cancer stem cells was attenuated. Moreover, PDAC-derived EVs induced the phosphorylation of Smad2/3 in NK cells. Serum EVs’ TGF-β1 was significantly increased in PDAC patients. Our findings emphasize the immunosuppressive role of PDAC-derived EVs and provide new insights into our understanding of NK cell dysfunction regarding pre-metastatic niche formation in PDAC.

7 December 2017 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
MBMarc Bludau
Marc Bludau
HFHans F. Fuchs
Hans F. Fuchs
THTill Herbold
Till Herbold
MMMartin K. H. Maus
Martin K. H. Maus
HAHakan Alakus
Hakan Alakus
SCSeung-Hun Chon
Seung-Hun Chon

29 January 2015 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
UWUte Warnecke-Eberz
Ute Warnecke-Eberz
SCSeung-Hun Chon
Seung-Hun Chon
AHArnulf H. Hölscher
Arnulf H. Hölscher
UDUta Drebber
Uta Drebber
EBElfriede Bollschweiler
Elfriede Bollschweiler

29 October 2018 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
FBFelix Berlth
Felix Berlth
MBMarc Bludau
Marc Bludau
PPPatrick Sven Plum
Patrick Sven Plum
THTill Herbold
Till Herbold
HCHildegard Christ
Hildegard Christ
SCSeung-Hun Chon
Seung-Hun Chon

21 April 2020 in Endoscopy
Verified
Journal Article
Closed access
PDF file
PSPasquale Scognamiglio
Pasquale Scognamiglio
MRMatthias Reeh
Matthias Reeh
KKKarl Karstens
Karl Karstens
EBEugen Bellon
Eugen Bellon
MKMarcus Kantowski
Marcus Kantowski
MTMichael Tachezy
Michael Tachezy
Background Esophageal anastomotic leakage still represents a challenging complication after esophageal surgery. Endoscopically placed self-expandable metal stents (SEMS) are the treatment of choice, but since the introduction of endoscopic vacuum therapy (EVT) for esophageal leakage 10 years ago, increasing evidence has demonstrated that EVT might be a superior alternative. Therefore, we performed a systematic review and meta-analysis to compare the effectiveness and related morbidity of SEMS and EVT in the treatment of esophageal leak. Methods We systematically searched for studies comparing SEMS and EVT to treat anastomotic leakage after esophageal surgery. Predefined end points including outcome, treatment success, endoscopy, treatment duration, hospitalization time, morbidity, and mortality were assessed and included in the meta-analysis. Results Five retrospective studies including 274 patients matched the inclusion criteria. Compared with stenting, EVT was significantly associated with a higher rate of leak closure (odds ratio [OR] 3.14, 95 % confidence interval [CI] 1.23 to 7.98), more endoscopic device changes (pooled median difference of 3.09; 95 %CI 1.54 to 4.64]), a shorter duration of treatment (pooled median difference –11.90 days; 95 %CI –18.59 to –5.21 days), and a lower mortality rate (OR 0.39, 95 %CI 0.18 to 0.83). There were no significant differences in short-term and major complications. Conclusions Owing to the retrospective quality of the studies with potential biases, the results of the meta-analysis must be interpreted with caution. However, the analysis indicates the potential benefit of EVT, which should be further investigated with standardized and prospectively collected data.